Edition:
United Kingdom

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

214.55USD
23 Jan 2018
Change (% chg)

$-0.77 (-0.36%)
Prev Close
$215.32
Open
$215.58
Day's High
$217.19
Day's Low
$214.25
Volume
457,704
Avg. Vol
446,804
52-wk High
$217.19
52-wk Low
$140.00

Latest Key Developments (Source: Significant Developments)

Thermo Fisher Scientific Completes Acquisition of Phenom-World
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC - ‍WILL INTEGRATE PHENOM-WORLD​ BUSINESS INTO CO'S ANALYTICAL INSTRUMENTS SEGMENT; TERMS OF DEAL NOT DISCLOSED.THERMO FISHER SCIENTIFIC INC - ‍COMPLETED ACQUISITION OF PHENOM-WORLD​.  Full Article

Juno Therapeutics And Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Juno Therapeutics Inc ::JUNO THERAPEUTICS AND THERMO FISHER SCIENTIFIC ANNOUNCE CAR T MANUFACTURING PARTNERSHIP.JUNO THERAPEUTICS - OBTAINED RIGHTS TO USE CTS DYNABEADS CD3/CD28 MAGNETIC BEADS FOR CLINICAL, COMMERCIAL MANUFACTURING PROCESSES FOR CAR T THERAPIES.JUNO THERAPEUTICS INC - NO OTHER TERMS FROM THIS TRANSACTION WERE DISCLOSED.  Full Article

Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets From Eptek Technology
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC ACQUIRES CONTINUOUS EMISSION MONITORING ASSETS FROM EPTEK TECHNOLOGY.THERMO FISHER SCIENTIFIC INC - TERMS OF TRANSACTION WERE NOT DISCLOSED.​.  Full Article

Evoke Pharma signs commercial agreement with Thermo Fisher Scientific
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Evoke Pharma Inc ::Signs commercial agreement with Thermo Fisher Scientific.Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​.Under five-year agreement, Thermo Fisher will manufacture Gimoti for Evoke's potential commercial efforts​.  Full Article

Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cellular Biomedicine Group Inc :Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes.Cellular Biomedicine Group Inc - ‍partnership focuses on research and development of an automated cell therapy manufacturing system​.  Full Article

Thermo Fisher enters agreement with Blueprint Medicines​
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Thermo Fisher Scientific Inc TMO.N:Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​.Thermo Fisher Scientific - co will retain rights to commercialize test globally, to lead necessary filings to seek clearance from regulatory agencies.Thermo Fisher Scientific Inc - ‍agreement to develop and commercialize Oncomine Dx Target Test as a companion diagnostic for BLU-667​.  Full Article

Thermo Fisher Scientific reports Q3 Adj EPS of $2.31
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Thermo Fisher Scientific Inc ::Q3 GAAP earnings per share $1.34; Q3 adjusted earnings per share $2.31.Q3 revenue up 14 percent to $5.1 billion.Raising revenue 2017 guidance to range of $20.50 billion to $20.66 billion, from $19.71 billion to $19.89 billion.Raising 2017 adjusted earnings per share guidance to range of $9.29 to $9.38, from $9.15 to $9.28.Q3 earnings per share view $2.25, revenue view $5.03 billion -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $9.35, revenue view $20.51 billion -- Thomson Reuters I/B/E/S.  Full Article

TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CFO
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Tetraphase Pharmaceuticals Inc ::TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER.‍MOST RECENTLY, KAMALAM UNNINAYAR​ SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC.KAMALAM UNNINAYAR MOST RECENTLY SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC​.  Full Article

Thermo Fisher Scientific announces receipt of all required regulatory approvals for proposed acquisition of Patheon
Wednesday, 23 Aug 2017 

Aug 23 (Reuters) - Thermo Fisher Scientific Inc :Thermo Fisher Scientific announces receipt of all required regulatory approvals for proposed acquisition of patheon.Thermo Fisher Scientific Inc - European Commission approved transaction today​.  Full Article

Thermo Fisher Scientific receives early termination of Hart-Scott-Rodino waiting period for acquisition of Finesse Solutions
Monday, 13 Feb 2017 

Thermo Fisher Scientific Inc : Thermo Fisher Scientific receives early termination of Hart-Scott-Rodino waiting period for acquisition of Finesse Solutions Inc .Thermo Fisher Scientific Inc - Thermo Fisher expects to complete acquisition of Finesse Solutions in coming days.  Full Article

BRIEF-Thermo Fisher Scientific Completes Acquisition of Phenom-World

* THERMO FISHER SCIENTIFIC - ‍WILL INTEGRATE PHENOM-WORLD​ BUSINESS INTO CO'S ANALYTICAL INSTRUMENTS SEGMENT; TERMS OF DEAL NOT DISCLOSED